Neuphoria Therapeutics Cash Flow Statement 2021-2025 | NEUP

Net Income/Loss

$-15.492

$-21.382

$-15.786

$-6.498

Total Depreciation And Amortization - Cash Flow

$0.663

$0.805

$1.271

Other Non-Cash Items

$-1.307

$1.496

$3.262

$-1.626

Total Non-Cash Items

$-0.644

$2.16

$4.067

$-0.355

Change In Accounts Receivable

$0.299

$4.137

$-0.028

$0.026

Change In Inventories

Change In Accounts Payable

$0.804

$0.374

$0.711

$-0.047

Change In Assets/Liabilities

$0.351

$0.073

$-4.747

$1.242

Total Change In Assets/Liabilities

$1.455

$4.585

$-4.064

$1.22

Cash Flow From Operating Activities

$-14.681

$-14.638

$-15.784

$-5.633

Net Change In Property, Plant, And Equipment

$0.126

$0.026

Net Change In Intangible Assets

Net Acquisitions/Divestitures

Net Change In Short-term Investments

$0.316

$-0.089

Net Change In Long-Term Investments

Net Change In Investments - Total

$0.316

$-0.089

Investing Activities - Other

$0.009

$0.003

Cash Flow From Investing Activities

$0.451

$-0.06

Net Long-Term Debt

$-8.284

Net Current Debt

$-0.126

$-0.583

Debt Issuance/Retirement Net - Total

$-0.126

$-8.867

Net Common Equity Issued/Repurchased

$15.109

$3.859

$23.862

$32.754

Net Total Equity Issued/Repurchased

$15.109

$3.859

$23.862

$32.754

Total Common And Preferred Stock Dividends Paid

Financial Activities - Other

$-4.15

$-0.31

Cash Flow From Financial Activities

$15.109

$3.859

$19.585

$23.577

Net Cash Flow

$0.505

$-11.023

$3.675

$17.874

Stock-Based Compensation

$0.815

$1.345

$2.053

$0.978

Common Stock Dividends Paid